scPharmaceuticals, Inc. is a high-risk pharmaceutical company based in the United States. Specializing in the development and commercialization of products aimed at improving patient care and reducing healthcare costs. Their main product, Furoscix, is a patented formulation of furosemide for subcutaneous administration using a wearable sc2Wear Infusor. Improve patient care with ESG-focused pharmaceutical solutions from scPharmaceuticals, Inc.